Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2018 Dec 25

PMID 30581434

Citations 7

Authors

Athanasios Gkoutzourelas

Christos Liaskos

Maria G Mytilinaiou

Theodora Simopoulou

Christina Katsiari

Alexandra Tsirogianni

Dimitrios Daoussis

Thomas Scheper

Wolfgang Meyer

Dimitrios P Bogdanos

Lazaros I Sakkas

Affiliations

Soon will be listed here.

Abstract

Epitope mapping of anti-Ro52 antibodies (Abs) has been extensively studied in patients with Sjögren's syndrome (SjS) and systemic lupus erythematosus (SLE). Comprehensive epitope mapping in systemic sclerosis (SSc), where anti-Ro52 antibodies are also frequently detected, has not been performed. The aim of the present study was to fully characterize Ro52 epitopes in anti-Ro52-positive SSc using Ro52 fragments spanning the full antigen. Further analysis was made according to anti-Ro60 status. Epitope mapping was performed in 43 anti-Ro52-positive SSc patients. Seventy eight anti-Ro52-positive pathological controls, including 20 patients with SjS, 28 patients with SLE, 15 patients with dermatomyositis (DM), and 15 patients with primary biliary cholangitis (PBC), and 20 anti-Ro52-negative healthy individuals as normal controls were also tested. Five recombinant Ro52 fragments [Ro52-1 (aa 1-127), Ro52-2 (aa 125-268), Ro52-3 (aa 268-475), Ro52-4 (aa 57-180), and Ro52-5 (aa 181-320) were used to test reactivity by line-immunoassay and ELISA. Anti-Ro60 reactivity was tested by ELISA. All anti-Ro52 positive sera reacted with Ro52-2; none recognized Ro52-3. Antibodies against Ro52-1 were less frequently found in SSc than in SjS/SLE (11.6 vs. 41.7%, = 0.001); and antibodies against Ro52-4 were less frequently found in SSc than in SjS/SLE (27.9 vs. 50%, = 0.03). In SSc patients, reactivity against Ro52-1 was more frequent in anti-Ro52+/anti-Ro60+ than in anti-Ro52+/anti-Ro60-patients (33.3 vs. 0%, = 0.003). In this comprehensive analysis of Ro52 epitope mapping in SSc, the coiled coil domain remains the predominant epitope on Ro52. Contrary to SjS and SLE, patients with SSc fail to identify epitopic regions within the N-terminus of the protein, especially if they lack con-current anti-Ro60 reactivity.

Citing Articles

A single-centre study on abnormal antinuclear antibodies in children caused by intravenous infusion of gamma globulin.

Xu L, Zhou J, Zhang Y, Wang Y, Yan X, Wang L Front Immunol. 2024; 15:1410661.

PMID: 39091491 PMC: 11291197. DOI: 10.3389/fimmu.2024.1410661.

Working Algorithms and Detection Methods of Autoantibodies in Autoimmune Liver Disease: A Nationwide Study.

Munoz-Sanchez G, Perez-Isidro A, de Landazuri I, Lopez-Gomez A, Bravo-Gallego L, Garcia-Ormaechea M Diagnostics (Basel). 2022; 12(3).

PMID: 35328252 PMC: 8947365. DOI: 10.3390/diagnostics12030697.

TRIM21/Ro52 - Roles in Innate Immunity and Autoimmune Disease.

Jones E, Laidlaw S, Dustin L Front Immunol. 2021; 12:738473.

PMID: 34552597 PMC: 8450407. DOI: 10.3389/fimmu.2021.738473.

Sicca syndrome in the same family - the importance of anti-Ro60, anti-Ro52 and anti-La antibody profiling in Sjögren's syndrome.

Koszarny A, Majdan M Reumatologia. 2021; 59(4):260-264.

PMID: 34538957 PMC: 8436791. DOI: 10.5114/reum.2021.108653.

Multicentric Reticulohistiocytosis Exhibiting Positive HLA-B*07 and HLA-B*08: A Case Report.

Rezus E, Burlui M, Cardoneanu A, Haba D, Danciu M, Cozma R Medicina (Kaunas). 2020; 56(9).

PMID: 32911791 PMC: 7560105. DOI: 10.3390/medicina56090456.

References

Kinoshita G, Keech C, Sontheimer R, Purcell A, McCluskey J, Gordon T . Spreading of the immune response from 52 kDaRo and 60 kDaRo to calreticulin in experimental autoimmunity. Lupus. 1998; 7(1):7-11. DOI: 10.1191/096120398678919606. View

Beuers U, Gershwin M, Gish R, Invernizzi P, Jones D, Lindor K . Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'. Gastroenterology. 2015; 149(6):1627-9. DOI: 10.1053/j.gastro.2015.08.031. View

Fujimoto M, Shimozuma M, Yazawa N, Kubo M, Ihn H, Sato S . Prevalence and clinical relevance of 52-kDa and 60-kDa Ro/SS-A autoantibodies in Japanese patients with systemic sclerosis. Ann Rheum Dis. 1998; 56(11):667-70. PMC: 1752295. DOI: 10.1136/ard.56.11.667. View

Hudson M, Pope J, Mahler M, Tatibouet S, Steele R, Baron M . Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis. Arthritis Res Ther. 2012; 14(2):R50. PMC: 3446416. DOI: 10.1186/ar3763. View

Kvarnstrom M, Dzikaite-Ottosson V, Ottosson L, Gustafsson J, Gunnarsson I, Svenungsson E . Autoantibodies to the functionally active RING-domain of Ro52/SSA are associated with disease activity in patients with lupus. Lupus. 2013; 22(5):477-85. DOI: 10.1177/0961203313479420. View

Oke V, Wahren-Herlenius M . The immunobiology of Ro52 (TRIM21) in autoimmunity: a critical review. J Autoimmun. 2012; 39(1-2):77-82. DOI: 10.1016/j.jaut.2012.01.014. View

Menendez A, Gomez J, Escanlar E, Caminal-Montero L, Mozo L . Clinical associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies: Diagnostic utility of their separate detection. Autoimmunity. 2012; 46(1):32-9. DOI: 10.3109/08916934.2012.732131. View

Gregorio G, Choudhuri K, Ma Y, Pensati P, Iorio R, Grant P . Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection. Clin Exp Immunol. 2003; 133(3):404-13. PMC: 1808793. DOI: 10.1046/j.1365-2249.2003.02229.x. View

Bogdanos D, Baum H, Sharma U, Grasso A, Ma Y, Burroughs A . Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. J Hepatol. 2002; 36(1):14-21. DOI: 10.1016/s0168-8278(01)00252-5. View

10.

Rhodes D, Trowsdale J . TRIM21 is a trimeric protein that binds IgG Fc via the B30.2 domain. Mol Immunol. 2006; 44(9):2406-14. DOI: 10.1016/j.molimm.2006.10.013. View

11.

Wahren-Herlenius M, Muller S, Isenberg D . Analysis of B-cell epitopes of the Ro/SS-A autoantigen. Immunol Today. 1999; 20(5):234-40. DOI: 10.1016/s0167-5699(99)01458-9. View

12.

Topfer F, Gordon T, McCluskey J . Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A). Proc Natl Acad Sci U S A. 1995; 92(3):875-9. PMC: 42723. DOI: 10.1073/pnas.92.3.875. View

13.

Slobbe R, Pruijn G, Damen W, Van Der Kemp J, van Venrooij W . Detection and occurrence of the 60- and 52-kD Ro (SS-A) antigens and of autoantibodies against these proteins. Clin Exp Immunol. 1991; 86(1):99-105. PMC: 1554155. DOI: 10.1111/j.1365-2249.1991.tb05780.x. View

14.

Wodkowski M, Hudson M, Proudman S, Walker J, Stevens W, Nikpour M . Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival. Clin Exp Rheumatol. 2015; 33(4 Suppl 91):S131-5. View

15.

Shiboski C, Shiboski S, Seror R, Criswell L, Labetoulle M, Lietman T . 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol. 2016; 69(1):35-45. PMC: 5650478. DOI: 10.1002/art.39859. View

16.

Ricchiuti V, Briand J, Meyer O, Isenberg D, Pruijn G, Muller S . Epitope mapping with synthetic peptides of 52-kD SSA/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera. Clin Exp Immunol. 1994; 95(3):397-407. PMC: 1535087. DOI: 10.1111/j.1365-2249.1994.tb07010.x. View

17.

Polymeros D, Bogdanos D, Day R, Arioli D, Vergani D, Forbes A . Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease?. Gastroenterology. 2006; 131(1):85-96. DOI: 10.1053/j.gastro.2006.04.021. View

18.

Bozic B, Pruijn G, Rozman B, van Venrooij W . Sera from patients with rheumatic diseases recognize different epitope regions on the 52-kD Ro/SS-A protein. Clin Exp Immunol. 1993; 94(2):227-35. PMC: 1534241. DOI: 10.1111/j.1365-2249.1993.tb03436.x. View

19.

Sakkas L, Bogdanos D . Systemic sclerosis: New evidence re-enforces the role of B cells. Autoimmun Rev. 2015; 15(2):155-61. DOI: 10.1016/j.autrev.2015.10.005. View

20.

Espinosa A, Dardalhon V, Brauner S, Ambrosi A, Higgs R, Quintana F . Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J Exp Med. 2009; 206(8):1661-71. PMC: 2722164. DOI: 10.1084/jem.20090585. View